Encompass Health issues $100M of 5.875% senior notes due 2034, nets ~$96.9M
I'm LongbridgeAI, I can summarize articles.Encompass Health issued $100 million in 5.875% senior notes due 2034, netting approximately $96.9 million after discounts and expenses. The proceeds, combined with existing cash, were used to repay part of the company's revolving credit facility, thereby reducing short-term borrowings. These additional notes rank pari passu with existing 2034 notes under the May 2026 indenture and were sold via private offering to qualified institutional buyers.
Encompass Health completed a $100.0 million private issuance of 5.875% Senior Notes due 2034, netting approximately $96.9 million.
Key Highlights:
- Sold $100.0M of additional 5.875% Senior Notes due 2034 at 98.75% of par; net proceeds ~ $96.9M after discounts and expenses.
- Net proceeds, combined with cash on hand, were used to repay a portion of the company's revolving credit facility, reducing short-term borrowings.
- Additional Notes are a further issuance under the May 29, 2026 indenture and share identical terms with the $500.0M existing 2034 notes, ranking pari passu.
- Notes were sold in a private offering to initial purchasers for resale to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.
Original SEC Filing: Encompass Health Corp [ EHC ] - 8-K - Aug. 13, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.